p53 in dermatology.
F P
FP
Gasparro
D000818:Animals; D002294:Carcinoma, Squamous Cell / Q000209:etiology / Q000235:genetics; D004249:DNA Damage; D004260:DNA Repair; D005109:Extracellular Matrix / Q000235:genetics; D005347:Fibroblasts / Q000378:metabolism; D011564:Furocoumarins / Q000009:adverse effects; D016158:Genes, p53 / Q000235:genetics*; D006801:Humans; D007108:Immune Tolerance; D007627:Keloid / Q000235:genetics; D007636:Keratoacanthoma / Q000209:etiology / Q000235:genetics; D051379:Mice; D016296:Mutagenesis; D009154:Mutation / Q000235:genetics; D011701:PUVA Therapy / Q000009:adverse effects; D010641:Phenotype; D017319:Photosensitizing Agents / Q000009:adverse effects; D011565:Psoriasis / Q000188:drug therapy; D012871:Skin Diseases / Q000235:genetics*; D012878:Skin Neoplasms / Q000235:genetics; D016159:Tumor Suppressor Protein p53 / Q000235:genetics
D011564:Furocoumarins; D017319:Photosensitizing Agents; D016159:Tumor Suppressor Protein p53